Singapore markets closed

Novan, Inc. (NOVN)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
0.5159+0.0003 (+0.06%)
At close: 4:00PM EDT

0.4950 -0.02 (-4.05%)
Before hours: 5:39AM EDT

Full screen
Trade prices are not sourced from all markets
Previous close0.5156
Bid0.4950 x 1100
Ask0.5299 x 1000
Day's range0.4917 - 0.5489
52-week range0.2150 - 3.7200
Avg. volume16,186,470
Market cap70.92M
Beta (5Y monthly)-0.29
PE ratio (TTM)N/A
EPS (TTM)-0.7030
Earnings date19 May 2020 - 20 May 2020
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est2.75
  • GlobeNewswire

    Life Sciences Companies Investor Presentations Now Available for On-Demand Viewing

    NEW YORK, June 29, 2020 -- Life Sciences Investor Forum today announced that the presentations from the June 25th conference are now available for on-demand viewing at.

  • GlobeNewswire

    Novan Anticipates Current Cash Position Provides Sufficient Capital to Conduct Additional SB206 Phase 3 Pivotal Trial

    Novan, Inc. ("the Company" or "Novan") (NOVN) today announced that the Company anticipates that its current cash position will be sufficient to fund costs associated with conducting an additional Phase 3 pivotal trial for SB206 as a treatment for molluscum, or B-SIMPLE4 (Berdazimer Sodium In Molluscum Patients with Lesions). Since June 1, 2020, the Company has secured approximately $16.9 million in capital from the use of common stock purchase agreements with Aspire Capital Fund, LLC and the exercise of common stock warrants sold in its March 2020 public offering. The Company is targeting enrolling the first patient for B-SIMPLE4 in September 2020 and, if the trial is initiated on this timetable and not further impacted by the COVID-19 pandemic, top-line efficacy results would be targeted for late in the second quarter of 2021.

  • GlobeNewswire

    Novan to Present at Virtual Life Sciences Investor Forum on June 25

    Novan, Inc. (“the Company” or “Novan”) (NOVN) today announced that Paula Brown Stafford, the Company’s President and Chief Executive Officer, will present a corporate overview at the Life Sciences Investor Forum on Thursday, June 25, 2020 at 2:00 p.m. Eastern. This will be a live, interactive online event where investors are invited to ask the company questions in real-time. The presentation and Q&A session will be webcast live and can be accessed through the Events page of the For Investors section of the Company's website at or at